Systemic therapy for advanced adrenal cancer.
The systemic management of advanced adrenal cancer remains a major therapeutic dilemma as it is both highly resistant to systemic agents and very rare epithelial neoplasm making clinical investigation a significant challenge. The role of mitotane, systemic chemotherapy and novel targeted agents are reviewed.
Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA. Dreicer@ccf.org
SourceJournal of surgical oncology 106:5 2012 Oct 1 pg 643-6
MeSHAdrenal Gland Neoplasms
Pub Type(s)Journal Article